Plaintiff Margie W. has filed an Invokana ketoacidosis lawsuit on behalf of decedent Ronald S. against the diabetes drug’s manufacturers, Janssen Pharmaceuticals, Inc. and Johnson & Johnson Co. Margie alleges Ronald suffered adverse effects and complications, including death and amputation, due to ingesting the diabetes medication.

Margie’s claims are filed as part of a large multidistrict litigation, or MDL, centered on allegations that the diabetes medication Invokana causes patients to suffer from serious adverse effects and complications, including diabetic ketoacidosis and amputation.

According to the Invokana ketoacidosis lawsuit, Ronald suffered “severe and personal injuries, including diabetic ketoacidosis, amputations, kidney failure, strokes, and myocardial infarctions” after taking diabetes medication Invokana.

According to Margie, Ronald was a resident of the state of Arkansas. He had begun taking Invokana in June 2015 until July 2015. He died later in August 2016.

The Invokana ketoacidosis lawsuit continues to maintain that soon after beginning treatment of the diabetic drug, Ronald suffered diabetic ketoacidosis and an amputation.

Margie seeks, according to the Invokana ketoacidosis lawsuit, “compensatory and punitive damages, monetary restitution, and all other available remedies as a result of injuries caused by Invokana.”

The Invokana ketoacidosis lawsuit maintains that the defendants, Janssen and J&J,  knew of the significant risks, adverse effects, and complications that may result from ingesting diabetic medication Invokana but failied to adequately inform patients and doctors of these risks.

The Invokana ketoacidosis lawsuit alleges, “defendants knew of the significant risk of diabetic ketoacidosis and amputations caused by ingestion of Invokana.”

“However, defendants did not adequately and sufficiently warn consumers, including plaintiff’s decedant, or the medical community of the severity of such risks,” the complaint says.

The Invokana ketoacidosis lawsuit files the following counts against the defendants. These include: 1) Product Liability Act- Manufacturing Defect, 2) Product Liability Act- Defective Design, 3) Product Liability Act- Failure to Warn, 4) Breach of Express Warranty, 5) Breach of Warranty of Fitness for Ordinary Use, 6) Negligence, 7) Breach of Implied Warranty, 8) Fraudulent Misrepresentation, 9) Negligent Misrepresentation, 10) Fraudulent Concealment, 11) Fraud, 12) Wrongful Death, 13) Survival Action, and 14) Punitive Damages Allegations.

Diabetes Medication Invokana Facts

Invokana, along with Invokamet and Invokamet XR, are of a class of type-2 diabetes medication that has been reported to cause patients to suffer from foot amputations, lower limb amputations, and diabetic ketoacidosis.

The U.S. Food and Drug Administration has warned the public of these risks in taking this class of medication. The class of drugs to which these diabetes medications are known as sodium-glucose cotransporter-2 (SGLT-2) inhibitors.

In May 2017, the FDA stated in an announcement, “Based on new data from two large clinical trials, the U.S. Food and Drug Administration (FDA) has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. We are requiring new warnings, including our most prominent Boxed Warning, to be added to the canagliflozin drug labels to describe this risk.”

The Invokana Ketoacidosis Lawsuit is Case No. 3:17-cv-08390-BRM-LHG. It’s part of the Invokana MDL, In re: Invokana (Canagliflozin) Products Liability Litigation, MDL No. 2750, in the U.S. District Court for the District of New Jersey.